MISONIX, Inc. (MSON) is a Medical Specialities company listed on NASDAQ. There were no new wire items for MSON in the last 30 days. The most recent was published Dec 8, 2021.
Latest news
25 items- INSIDERSEC Form 4: Koby Michael returned 1,744,017 shares to the company4 - MISONIX INC (0000880432) (Issuer)
- INSIDERSEC Form 4: Vizirgianakis Stavros G. returned 2,136,478 shares to the company, closing all direct ownership in the company4 - MISONIX INC (0000880432) (Issuer)
- INSIDERSEC Form 4: Patton Thomas M returned 104,500 shares to the company, closing all direct ownership in the company4 - MISONIX INC (0000880432) (Issuer)
- INSIDERSEC Form 4: Ludecker Robert S returned 319,443 shares to the company, closing all direct ownership in the company4 - MISONIX INC (0000880432) (Issuer)
- INSIDERSEC Form 4: Laviolette Paul A returned 1,744,017 shares to the company4 - MISONIX INC (0000880432) (Issuer)
- INSIDERSEC Form 4: Dwyer Joseph P returned 276,200 shares to the company, closing all direct ownership in the company4 - MISONIX INC (0000880432) (Issuer)
- INSIDERSEC Form 4: Beyer Pat returned 20,000 shares to the company, closing all direct ownership in the company4 - MISONIX INC (0000880432) (Issuer)
- SECSEC Form RW filed by MISONIX, Inc.RW - MISONIX INC (0000880432) (Filer)
- SECSEC Form 15-12B filed by MISONIX, Inc.15-12B - MISONIX INC (0000880432) (Filer)
- SECMISONIX, Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Changes in Control of Registrant, Leadership Update, Financial Statements and Exhibits8-K - MISONIX INC (0000880432) (Filer)
- SECSEC Form S-8 POS filed by MISONIX, Inc.S-8 POS - MISONIX INC (0000880432) (Filer)
- SECSEC Form S-8 POS filed by MISONIX, Inc.S-8 POS - MISONIX INC (0000880432) (Filer)
- SECSEC Form S-8 POS filed by MISONIX, Inc.S-8 POS - MISONIX INC (0000880432) (Filer)
- SECSEC Form S-8 POS filed by MISONIX, Inc.S-8 POS - MISONIX INC (0000880432) (Filer)
- SECSEC Form S-8 POS filed by MISONIX, Inc.S-8 POS - MISONIX INC (0000880432) (Filer)
- SECSEC Form S-8 POS filed by MISONIX, Inc.S-8 POS - MISONIX INC (0000880432) (Filer)
- SECSEC Form S-8 POS filed by MISONIX, Inc.S-8 POS - MISONIX INC (0000880432) (Filer)
- SECSEC Form S-8 POS filed by MISONIX, Inc.S-8 POS - MISONIX INC (0000880432) (Filer)
- SECSEC Form S-8 POS filed by MISONIX, Inc.S-8 POS - MISONIX INC (0000880432) (Filer)
- SECSEC Form S-8 POS filed by MISONIX, Inc.S-8 POS - MISONIX INC (0000880432) (Filer)
- SECSEC Form 25-NSE filed by MISONIX, Inc.25-NSE - MISONIX INC (0000880432) (Subject)
- SECMISONIX, Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits8-K - MISONIX INC (0000880432) (Filer)
- PRBioventus and Misonix Stockholders Approve the Acquisition of Misonix by BioventusDURHAM, N.C. and FARMINGDALE, N.Y., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (NASDAQ:BVS) ("Bioventus" or the "Company"), a global leader in innovations for active healing, and Misonix, Inc. (NASDAQ:MSON) ("Misonix"), a provider of minimally invasive therapeutic ultrasonic technologies and regenerative medicine that enhance clinical outcomes, today announced that the stockholders of Bioventus approved the issuance of shares of Bioventus class A common stock to the stockholders of Misonix in connection with the previously announced Agreement and Plan of Merger, dated July 29, 2021, by and among Bioventus, Misonix and other parties thereto, pursuant to which Misonix will be acquired
- SECSEC Form 425 filed by MISONIX, Inc.425 - MISONIX INC (0000880432) (Subject)
- SECSEC Form 8-K filed by MISONIX, Inc.8-K - MISONIX INC (0000880432) (Filer)
MSON FAQ
8 questionsWhat does MISONIX, Inc. do?
Misonix, Inc., together with its subsidiaries, designs, develops, manufactures, and markets minimally invasive surgical ultrasonic medical devices in the United States and internationally. The company's products include BoneScalpel, an ultrasonic bone cutting and sculpting system for surgical procedures involving the precise cutting and sculpting of bone while sparing soft tissue; SonaStar, a surgical aspirator, which is used to emulsify and remove soft and hard tumors primarily in the neuro and general surgery field; and SonicOne, an ultrasonic cleansing and debridement system that provides...What is the latest news on MSON?
Quantisnow has not tracked any new filings, ratings or press releases for MSON in the last 30 days. The most recent wire item was published on December 8, 2021.Where does MSON stock trade?
MISONIX, Inc. (MSON) is listed on NASDAQ.What sector and industry is MSON in?
MISONIX, Inc. operates in the Capital Goods sector, Medical Specialities industry.When did MISONIX, Inc. go public?
MISONIX, Inc. (MSON) completed its IPO in 1992.What are analysts saying about MSON?
Across the last 2 analyst actions on MISONIX, Inc., there were 0 upgrades and 2 downgrades. The most recent action was from BTIG: Neutral on 2021-08-02. Recent price targets cluster around $28.00.What companies are similar to MSON?
Notable peers in the same industry include HUM (Humana Inc.), NTRA (Natera Inc.), CI (The Cigna Group), UNH (UnitedHealth Group Incorporated), ILMN (Illumina Inc.). Compare MSON side-by-side with any of them on Quantisnow.How can I track MSON on Quantisnow?
Quantisnow aggregates MISONIX, Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow MSON to receive live email and push alerts on every new disclosure.